NewBridge Pharmaceuticals Email Format
Pharmaceutical ManufacturingDubai, United Arab Emirates201-500 Employees
NewBridge Pharmaceuticals is a regional specialty pharmaceutical company headquartered in Dubai, United Arab Emirates, employing 201-500 people. It aims to bridge the access gap by in-licensing and commercializing FDA or EMA-approved innovative pharmaceutics, biologics, and other healthcare solutions for the Middle East and Africa region. Its strategic focus areas include Oncology, Immunology, Neuroscience, Gastrointestinal and Rare Diseases, with a portfolio designed to address unmet medical needs in the region. The company offers flexible partnership opportunities and manages commercial, regulatory, and medical affairs activities while maintaining high standards of compliance. NewBridge has partnered with global biopharma companies, including supply and distribution arrangements with BioCryst Pharmaceuticals in the UAE and GCC/Iraq, and an exclusive license for RUCONEST with Pharming Group in the MENA region, along with earlier partnerships such as Aramex in 2016.